EDITORIALS


Acesso aberto Revisado por pares

0

Visualização

Why we should use long-acting injectable antipsychotics more frequently

Why we should use long-acting injectable antipsychotics more frequently

Joao Paulo Maia-de-Oliveira1,2,3, Rodrigo A. Bressan4, Helio Elkis5, Joao Paulo Machado-de-Sousa1,2 , Jaime E.C. Hallak1,2

Vol.35 Issue 3/2013:

1. Department of Neuroscience and Behavior, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
2. National Science and Technology Institute for Translational Medicine (INCT-TM), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
3. Department of Clinical Medicine, Universidade Federal do Rio Grande do Norte (UFRN), Natal, RN, Brazil
4. Schizophrenia Program, Interdisciplinary Laboratory of Clinical Neurosciences, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
5. Schizophrenia Research Program and Department and Institute of Psychiatry, School of Medicine, USP, São Paulo, SP, Brazil Corresponding author
Jaime EC Hallak
Hospital das Clínicas da FMRP-USP
Av. Bandeirantes, 3900, 36 andar, Monte Alegre
CEP 14048-900, Ribeirão Preto, SP, Brazil
E-mail: jhallak@fmrp.usp.br

© 2026 All rights reserved